↓ Skip to main content

Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?

Overview of attention for article published in Arthritis Research & Therapy, October 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#23 of 2,226)
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
5 news outlets
blogs
1 blog
twitter
4 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
Published in
Arthritis Research & Therapy, October 2017
DOI 10.1186/s13075-017-1445-3
Pubmed ID
Authors

Vasco C. Romão, Edward M. Vital, João Eurico Fonseca, Maya H. Buch

Abstract

Individualising biologic disease-modifying anti-rheumatic drugs (bDMARDs) to maximise outcomes and deliver safe and cost-effective care is a key goal in the management of rheumatoid arthritis (RA). Investigation to identify predictive tools of bDMARD response is a highly active and prolific area of research. In addition to clinical phenotyping, cellular and molecular characterisation of synovial tissue and blood in patients with RA, using different technologies, can facilitate predictive testing. This narrative review will summarise the literature for the available bDMARD classes and focus on where progress has been made. We will also look ahead and consider the increasing use of 'omics' technologies, the potential they hold as well as the challenges, and what is needed in the future to fully realise our ambition of personalised bDMARD treatment.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 21%
Researcher 8 15%
Other 5 10%
Student > Bachelor 3 6%
Lecturer 3 6%
Other 13 25%
Unknown 9 17%
Readers by discipline Count As %
Medicine and Dentistry 16 31%
Pharmacology, Toxicology and Pharmaceutical Science 7 13%
Biochemistry, Genetics and Molecular Biology 6 12%
Immunology and Microbiology 4 8%
Agricultural and Biological Sciences 3 6%
Other 6 12%
Unknown 10 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 54. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2018.
All research outputs
#336,368
of 13,799,368 outputs
Outputs from Arthritis Research & Therapy
#23
of 2,226 outputs
Outputs of similar age
#14,778
of 316,258 outputs
Outputs of similar age from Arthritis Research & Therapy
#1
of 202 outputs
Altmetric has tracked 13,799,368 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,226 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 316,258 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 202 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.